Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/3161
Title: | In Vitro and In Vivo Demonstration of Human-Ovarian-Cancer Necrosis through a Water-Soluble and Near-Infrared-Absorbing Chlorin |
Authors: | Marydasan, B Madhuri, B Cherukommu, S Jose, J Viji, M Karunakaran, S C Chandrashekar, T K Rao, K S Rao, CM Ramaiah, D |
Issue Date: | 14-Jun-2018 |
Publisher: | American Chemical Society |
Citation: | Journal of Medicinal Chemistry, 61(11):5009-5019 |
Abstract: | With the objective of developing efficient sensitizers for therapeutic applications, we synthesized a water-soluble 5,10,15,20-tetrakis(3,4-dihydroxyphenyl)chlorin (TDC) and investigated its in vitro and in vivo biological efficacy, comparing it with the commercially available sensitizers. TDC showed high water solubility (6-fold) when compared with that of Foscan and exhibited excellent triplet-excited-state (84%) and singlet-oxygen (80%) yields. In vitro photobiological investigations in humanovarian- cancer cell lines SKOV-3 showed high photocytotoxicity, negligible dark toxicity, rapid cellular uptake, and specific localization of TDC in neoplastic cells as assessed by flow-cytometric cell-cycle and propidium iodide staining analysis. The photodynamic effects of TDC include confirmed reactive-oxygen-species-induced mitochondrial damage leading to necrosis in SKOV-3 cell lines. The in vivo photodynamic activity in nude-mouse models demonstrated abrogation of tumor growth without any detectable pathology in the skin, liver, spleen, or kidney, thereby demonstrating TDC application as an efficient and safe photosensitizer. |
URI: | http://10.10.100.66:8080/xmlui/handle/123456789/3161 |
Appears in Collections: | 2018 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
In Vitro and In Vivo Demonstration of Human-Ovarian-Cancer-Betsy Marydasan-Journal of Medicinal Chemistry.pdf Restricted Access | 7.87 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.